| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.4 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.05 | 0.4 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.4 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |